You are here: Industry Insights > SARS-CoV-2

News List

Pneumagen Announces Neumifil is Efficacious in Established Model of COVID-19 Infection americanpharmaceuticalreview
March 12, 2021
Pneumagen announced a further milestone in the development of Neumifil™ for the treatment of COVID-19. Utilizing a hamster model of COVID-19 infection, researchers showed Neumifil was efficacious, significantly reducing clinical signs and weight loss ...
CEPI and VBI to develop vaccines against SARS-CoV-2 variants pharmaceutical-technology
March 12, 2021
The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants.
Abbott Receives EUA for PCR Assay That Detects, Differentiates SARS-CoV-2, Flu, RSV in One Test americanpharmaceuticalreview
March 11, 2021
Abbott announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity™ m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) ...
GeoVax Expands Intellectual Property Portfolio americanpharmaceuticalreview
March 09, 2021
GeoVax Labs announced the filing of two additional patent applications important to the Company’s key focus on vaccines against SARS-CoV-2 (COVID-19) and cancer immunotherapies.
Researchers discover SARS-CoV-2 inhibitors worldpharmanews
March 05, 2021
A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus.
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection prnasia
March 05, 2021
Oxford Immunotec Global PLC., a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative detection of a cell mediated (T cell) immune response to ...
Bio-Rad Introduces Bio-Plex Pro Human IgG SARS-CoV-2 Serology Assays americanpharmaceuticalreview
March 03, 2021
Bio-Rad Laboratories announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel, for research use only (RUO).
AIVITA Completes Phase 1 Study of Personalized COVID-19 Vaccine Candidate americanpharmaceuticalreview
March 02, 2021
AIVITA Biomedical announced the completion of a Phase 1 clinical study in Indonesia of its personalized vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2).
Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test Service americanpharmaceuticalreview
March 01, 2021
Quest Diagnostics has introduced a new COVID-19 testing service that aids in providing insight into an individual's immune response as a result of a recent or prior infection with SARS-CoV-2, the virus that causes COVID-19, or to immune response ...
Vela Diagnostics adds two SARS-CoV-2 assays for virus genotyping, and variant identification to its COVID-19 testing solutions prnasia
February 26, 2021
Vela Diagnostics announced that it has added ViroKey™ SQ FLEX SARS-CoV-2 Genotyping Assay and ViroKey™ SARS-CoV-2 ID RT-PCR Test to its portfolio offering.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page